HIQA commences assessment of RSV immunisation for the 2026-2027 season and beyond

HIQA has published a protocol for a HTA of immunisation of infants and or adults aged 65 and older against RSV in Ireland.

By Danielle Norton January 28, 2025 Updated January 30, 2025 2 min read

The Health Information and Quality Authority (HIQA) has published a protocol for a health technology assessment (HTA) of immunisation of infants and or adults aged 65 and older against respiratory syncytial virus (RSV) in Ireland.

The primary objective of this HTA is to provide advice to the Minister for Health and Health Service Executive (HSE) to inform a policy decision on the most appropriate RSV immunisation strategy for infants and or adults aged 65 and older in Ireland for the 2026-2027 and subsequent RSV seasons.